title: Editorial: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze.
authors.affiliation: Department of Psychiatry and Addiction Medicine, CHU Lille, Lille France Department of Pharmacology, INSERM U1171. benjamin.rolland@chru-lille.fr.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Rolland
authors.affiliation: King's College London, Institute of Psychiatry, Psychology and Neuroscience London, UK Centre for Neuroimaging Sciences. ali.amad@kcl.ac.uk.
authors.forename: Ali
authors.initials: A
authors.lastname: Amad
mesh_terms: D006801:Humans; D057970:Inappropriate Prescribing; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D056687:Off-Label Use; D061214:Patient Safety; D010818:Practice Patterns, Physicians'; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D011619:Psychotropic Drugs